These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 303057)

  • 1. Immunologic evaluation and prognosis in patients with head and neck cancer.
    Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
    Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
    Bier J; Nicklisch U
    Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
    Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
    J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
    Das SN; Khanna NN; Khanna S
    Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
    Zighelboim J; Dorey F; Parker NH; Calcaterra T; Ward P; Fahey JL
    Cancer; 1979 Jul; 44(1):117-23. PubMed ID: 313240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of preoperative immunologic test results with recurrence in patients with head and neck cancer.
    Ryan RE; Neel HB; Ritts RE
    Otolaryngol Head Neck Surg (1979); 1980; 88(1):58-63. PubMed ID: 6967203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region.
    Bier J; Nicklisch U; Platz H
    Cancer; 1983 Oct; 52(7):1165-72. PubMed ID: 6603897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW
    Cancer; 1977 May; 39(5):2137-41. PubMed ID: 322852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiologic staging of patients with carcinoma of the head and neck.
    Katz AE
    Laryngoscope; 1983 Apr; 93(4):445-63. PubMed ID: 6339850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune response in head and neck cancer patients.
    Olivari A; Pradier R; Feierstein J; Guardo A; Glait H; Rojas A
    J Surg Oncol; 1976; 8(4):287-94. PubMed ID: 781404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.